Added to YB: 2026-08-14
Pitch date: 2026-08-12
HIMS [neutral]
Hims & Hers Health, Inc.
-3.26%
current return
Author Info
No bio for this author
Company Info
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.
Market Cap
$7.0B
Pitch Price
$29.74
Price Target
N/A
Dividend
N/A
EV/EBITDA
853.11
P/E
-48.19
EV/Sales
2.99
Sector
Health Care Providers and Services
Category
growth
Honest Hims Q2'26 Review: The Good and The Bad
HIMS (earnings): Q2'26 rev $753M (+38% YoY) beat $730M est but EPS -$0.37 vs -$0.05 est. Gross margin fell 76%→64%; op loss $97M. Growth largely inorganic (Eucalyptus). US organic +16%, ARPU +21% to $92. FCF -$68M, leverage up ($1.37B convts). FY26 guide raised to $3.1-3.3B. Q3 margin recovery is key test.
Read full article (10 min)